|
    ABMD U.S.: Nasdaq

    Abiomed Inc.

    ABMDUS
    After Hours
    Back To Top
    Last Updated: May 7, 2021 4:57 p.m. EDT Delayed quote

    $ 296.81

    0.00 0.00%
    After Hours Volume: 19.45K
    Close Chg Chg %
    $296.81 1.09 0.37%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 183.27K 65 Day Avg: 282.86K
    65% vs Avg
    296.35 Day Range 303.86
    180.29 52 Week Range 387.40

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABMD Overview

    Performance

    5 Day
    • -7.46%
    1 Month
    • -11.08%
    3 Month
    • -9.47%
    YTD
    • -8.45%
    1 Year
    • 58.66%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 9 Full Ratings

    Recent News

    • eLesor
    • Dow Jones
    Read full story

    Abiomed Inc. stock rises Friday, still underperforms market

    Read full story

    Abiomed Inc. stock falls Thursday, underperforms market

    Read full story

    Abiomed Inc. stock underperforms Wednesday when compared to competitors

    Read full story

    Abiomed Inc. stock falls Tuesday, underperforms market

    Read full story

    Abiomed Inc. stock falls Monday, underperforms market

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock underperforms Thursday when compared to competitors

    Read full story

    Abiomed Inc. stock underperforms Wednesday when compared to competitors despite daily gains

    Read full story

    Abiomed Inc. stock underperforms Tuesday when compared to competitors

    Read full story

    Abiomed Inc. stock outperforms competitors despite losses on the day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock underperforms Thursday when compared to competitors despite daily gains

    Read full story

    Abiomed Inc. stock outperforms competitors on strong trading day

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock outperforms market despite losses on the day

    Read full story

    Abiomed Inc. stock falls Friday, underperforms market

    Read full story

    Abiomed Inc. stock outperforms market on strong trading day

    Read full story

    Abiomed Inc. stock underperforms Wednesday when compared to competitors despite daily gains

    Read full story

    Abiomed Inc. stock underperforms Tuesday when compared to competitors

    Read full story

    Abiomed Inc. stock underperforms Monday when compared to competitors

    • Other News
    • Press Releases

    New Strong Sell Stocks for May 4th

    on Zacks.com

    Abiomed to Shareholders: Patience Please, Growth Is On The Way.

    on Motley Fool

    The End of the Pandemic Will Mean a Major Boost for These 2 Buy-and-Hold Stalwarts

    on Motley Fool

    BTIG Sticks to Their Hold Rating for Abiomed (ABMD)

    on SmarterAnalyst

    ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q4

    on Zacks.com

    Abiomed Inc (ABMD) Q4 2021 Earnings Call Transcript

    on Motley Fool

    Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates

    on Zacks.com

    Analysts Conflicted on These Healthcare Names: Abiomed (ABMD), Amgen (AMGN) and Stryker (SYK)

    on SmarterAnalyst

    ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards?

    on Zacks.com

    Abiomed (ABMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    on Zacks.com

    3 Overlooked Healthcare Stocks to Buy Right Now

    on Motley Fool

    Buy These 3 Breakout Healthcare Stocks if There's a Sell-Off or Correction

    on Motley Fool

    Better Buy for the Next 10 Years: Abiomed vs. Guardant Heath

    on Motley Fool

    Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed

    on Zacks.com

    3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

    on Zacks.com

    This Company Will Fix the Hidden COVID Danger to Come

    on Motley Fool

    CMD or ABMD: Which Is the Better Value Stock Right Now?

    on Zacks.com

    Abiomed (ABMD) Down 8.6% Since Last Earnings Report: Can It Rebound?

    on Zacks.com

    A Trio of High-Return Businesses with Solid Balance Sheets

    on GuruFocus.com

    Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio

    on Zacks.com

    Abiomed Inc.

    ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.

    Competitors

    Name Chg % Market Cap
    AtriCure Inc. -0.05% $3.54B
    Boston Scientific Corp. 0.21% $61.27B
    Stereotaxis Inc. 4.52% $496.34M
    Teleflex Inc. 1.23% $19.28B
    Competitor Data Provided ByCapital Cube Logo